Open access
2,642
Views
11
CrossRef citations to date
0
Altmetric
Research Paper
Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumour effects in vivo
Shushan Gea State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing, PR China
https://orcid.org/0000-0003-2812-1376View further author information
Haiqing Zhongb State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, PR ChinaView further author information
, Xuewei Maa State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing, PR ChinaView further author information
, Yingbo Zhenga State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing, PR ChinaView further author information
, Yi Zoua State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing, PR ChinaView further author information
, Fang Wanga State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing, PR ChinaView further author information
, Yan Wangb State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, PR ChinaView further author information
, Yue Hub State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, PR ChinaView further author information
, Yuezhen Lic Department of Organic Chemistry, School of Science, China Pharmaceutical University, Nanjing, PR ChinaView further author information
, Wen Liub State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, PR ChinaView further author information
, Wenjie Guob State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, PR ChinaCorrespondence[email protected]
https://orcid.org/0000-0001-8506-3905View further author information
Qiang Xub State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, PR ChinaCorrespondence[email protected]
View further author information
& View further author information
Yisheng Laia State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing, PR ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-8026-7949View further author information
Pages 1240-1257
|
Received 27 Feb 2020, Accepted 30 Apr 2020, Published online: 28 May 2020
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.